EPALEX CORP

Profile

Company Names

EPALEX CORP

Addresses

1049 EL MONTE AVENUE, SUITE C585, MOUNTAIN VIEW, CA 94040

1049 EL MONTE AVENUE, SUITE C 585, MOUNTAIN VIEW, CA 94040

4725 FIRST STREET #250, PLEASANTON, CA 94566

Phone Numbers

650-946-3366 X700
659-946-3366 X700
(650)346-3380

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$30,756,175.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2025-10-31 
$1,200,000.00 
$3,199,991.00 
$1,999,991.00 
Equity 
4
2024-12-09 
$3,999,999.00 
$14,999,998.00 
$10,999,999.00 
Equity 
3
2022-10-04 
$4,260,617.00 
$8,499,980.00 
$4,239,363.00 
Equity 
2
2018-12-31 
$20,296,275.00 
$20,296,275.00 
$0.00 
Equity 
1
2017-09-01 
$999,284.00 
$1,000,000.00 
$716.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ENRIQUE 
CARRAZANA 
DIRECTOR
DIDRIC 
 
CEDARHOLM 
DIRECTOR
STEVEN 
LINCOLN 
EXECUTIVE OFFICER
BRENDAN 
 
MAGRAB 
EXECUTIVE OFFICER, DIRECTOR
RANDALL 
 
MURPHY 
DIRECTOR
RANDALL 
MURPHY 
DIRECTOR
ARTHUR 
FRANKLIN 
RICE 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
 
ROGAWSKI 
DIRECTOR
MICHAEL 
ROGAWSKI 
DIRECTOR
JON 
SAXE 
DIRECTOR
JON 
S. 
SAXE 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-31 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-09 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-04 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-31 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-31 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#